Editorial
the association between MAO abnormalities and aggressive behavior, possible mechanisms underlying vulnerability to environmental adversity in the pathogenesis of aggression, as well as therapeutic strategies focusing on MAO targets. Encoded by separate genes on the X chromosome, MAO-A and B both catalyze the breakdown of amines but have different catalytic properties, distinctly different distribution across the brain and diverse effects on various personality traits and behaviors.
By way of introduction, Ramsay (2016) has reviewed the molecular aspects of MAO, focusing particularly on the B form of MAO (MAO-B). MAO-B is constitutively expressed throughout the body but is the predominant form in platelets and glial cells. Lower MAO activity means higher amine levels and vice versa as established by urinary and postmortem measurements, or by microdialysis in rats. A brief description of the classic work on MAO expression is updated with recent observations of epigenetic regulation of MAO activity. MAO inhibition raises brain amine levels, a fact exploited for antidepressant effect, and now being incorporated into multi-target compounds to combat neurodegenerative conditions. Catalysis, mechanism and inhibition of MAO, important both for measuring levels in tissues and for drug design, are described. Of the successful irreversible drugs that inhibit MAO-B, the classic non-selective MAO inhibitor, phenelzine, the MAO-B selective inhibitor deprenyl (selegiline, now commonly used in Parkinson's disease), and the cyclopropylamine, parnate, are highlighted, along with lazabemide as a reversible inhibitor. Recent developments in reversible inhibitor design include some compounds with nanomolar affinity but there is no indication that they will be successful in vivo. In the meantime, the traditional irreversible inhibitors are effective and well understood drugs.
Behavioral links with MAO activity have been greatly advanced by recent translational work informed by transgenic mice. In their article, Bortolato and colleagues (Godar et al., 2016) review the role of monoamine oxidase A (MAO-A) in the ontogeny of aggression. The first discovery of a connection between the MAOA gene and antisocial behavior came from the identification of a rare null-allele mutation and high propensity for violent crimes in the males of a Dutch family. Following this finding, several investigations have identified that aggression propensity is influenced by a functional VNTR (variable number of tandem repeats) polymorphism of the promoter of this gene; in particular, numerous independent studies have shown that low-activity VNTR alleles may interact with child abuse and/or neglect to facilitate the development of aggressive traits in adolescence and adulthood. In addition, several brain-imaging studies have identified that MAO-A low-activity alleles are associated with alterations of cortico-amygdalar connectivity. The neurobiological underpinnings of these phenomena, however, remain poorly understood. A promising tool to investigate these issues is afforded by animal models, most notably mouse harboring hypomorphic mutations of MAOA. Phenotypical analyses of these transgenic animals have revealed numerous elements of convergence with human data; in particular, Godar et al. (2016) show how the integration of animal and human studies is likely to refine our current understanding of the neurodevelopmental mechanisms of aggression, and assist in the development of novel therapies.
Harro and Oreland (2016) cover the history and state of the art of the studies describing the links between MAO and personality, with focus on alcohol abuse.
Both MAO-A and MAO-B have been implicated in shaping personality and regulation of behavior, but their stories differ with regard to how either of the isoenzymes came to the research limelight, what has most frequently been measured, what has been found and what their roles appear to be. While most of the studies are consistent in associating both MAO-A and MAO-B with impulsive, aggressive or antisocial personality traits or behavior, there are notable exceptions, and attempts to explain these divergent findings that have provided insights into the salience of developmental aspects and gender roles. Adverse environmental factors, especially in childhood, strongly interact with the MAO measures in predicting future behavior but, importantly, the "risk variants" seem to increase not simply vulnerability but plasticity, hence being advantageous in supportive environments. Nevertheless, there is little evidence that variation in MAO activity in adulthood is the source of variation in the brain plasticity; indeed, it may be that the time window is already in the fetal period when monoamine neurotransmitters elicit their neurotrophic effects and serve as a source of differences in brain structure and functional connectivity. A possibility to look into this early period is provided by the only isoenzyme present in platelets (MAO-B) that remains uninfluenced by the epigenetic effects of life events on the brain and may inform on the enzyme activity during early development. While the location of the MAO genes on the X chromosome obviously contributes to at least some of the sex differences found in gene-environment interactions, the gender roles may act as hitherto unrecognized significant mediators that lead to the remarkably different findings in males and females (Harro and Oreland, 2016) . 
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